MedPath

Clinical study of siddha medicine Nandhi mezhugu in the treatment of Rheumatoid arthritis

Phase 2
Completed
Conditions
Health Condition 1: null- UTHIRAVATHASURONITHAM(RHEUMATOID ARTHRITIS)
Registration Number
CTRI/2018/05/013762
Lead Sponsor
AYOTHIDOSS PANDITHAR HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.Pain and swelling in smaller and major joints.

2.Symmetrical joint involvement.

3.More than 3 joints involved.

4.Fever.

5.Morning stiffness.

6.Serum positive Anti CCP

Exclusion Criteria

1.Diabetes mellitus.

2.Hypo & Hyperthyroidism.

3.Hypertension.

4.Cardiac disease.

5.Renal disease.

6.Liver disorder.

7.Neurological disorders.

8.Pregnancy and Lactation.

9.Alcoholism.

10.Recent treatment with steroids.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of pain(assessed by universal pain assessment scale) of the joints,and improvement in the movement of the affected joints( Restricted movement assessment scale) and improvement in the quality of life(assessed by Modified health assessment Questionnaire)Timepoint: AFTER COMPLETION OF 60 DAYS TREATMENT.
Secondary Outcome Measures
NameTimeMethod
1.Reduction of other clinical symptoms like low grade fever, anorexia etc. <br/ ><br>2.Reduction in Anti-CCP and RA factor. <br/ ><br>3.Reduction of ESR and CRP <br/ ><br>4. other variables like age , gender,occupation, socioeconomic status,seasonal variation,duration of illness will be studied . <br/ ><br>Timepoint: After the treatment period of 60 Days
© Copyright 2025. All Rights Reserved by MedPath